Logo image of BBLG

BONE BIOLOGICS CORP (BBLG) Stock Price, Quote, News and Overview

NASDAQ:BBLG - Nasdaq - US0980705018 - Common Stock - Currency: USD

0.7158  +0.01 (+1.52%)

BBLG Quote, Performance and Key Statistics

BONE BIOLOGICS CORP

NASDAQ:BBLG (4/23/2025, 1:15:14 PM)

0.7158

+0.01 (+1.52%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High4.25
52 Week Low0.64
Market Cap2.34M
Shares3.27M
Float3.27M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-12 2025-05-12/amc
IPO11-27 2015-11-27


BBLG short term performance overview.The bars show the price performance of BBLG in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40 -50

BBLG long term performance overview.The bars show the price performance of BBLG in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of BBLG is 0.7158 USD. In the past month the price decreased by -17.05%. In the past year, price decreased by -53.91%.

BONE BIOLOGICS CORP / BBLG Daily stock chart

BBLG Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 17.4 311.43B
AMGN AMGEN INC 14.05 149.73B
GILD GILEAD SCIENCES INC 22.94 131.86B
VRTX VERTEX PHARMACEUTICALS INC 1700.55 126.78B
REGN REGENERON PHARMACEUTICALS 12.95 64.59B
ARGX ARGENX SE - ADR 322.59 36.64B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 31.51B
BNTX BIONTECH SE-ADR N/A 27.80B
ONC BEIGENE LTD-ADR N/A 27.01B
SMMT SUMMIT THERAPEUTICS INC N/A 22.86B
NTRA NATERA INC N/A 20.44B
BIIB BIOGEN INC 7.18 17.31B

About BBLG

Company Profile

BBLG logo image Bone Biologics Corp. operates as a medical device company. The company is headquartered in Burlington, Massachusetts and currently employs 2 full-time employees. The company went IPO on 2015-11-27. The firm is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Company Info

BONE BIOLOGICS CORP

2 Burlington Woods Dr Ste 100

Burlington MASSACHUSETTS US

Employees: 2

Company Website: https://www.bonebiologics.com/

Investor Relations: http://www.bonebiologics.com/investor-relations/

Phone: 17815524452

BONE BIOLOGICS CORP / BBLG FAQ

What is the stock price of BONE BIOLOGICS CORP today?

The current stock price of BBLG is 0.7158 USD. The price increased by 1.52% in the last trading session.


What is the ticker symbol for BONE BIOLOGICS CORP stock?

The exchange symbol of BONE BIOLOGICS CORP is BBLG and it is listed on the Nasdaq exchange.


On which exchange is BBLG stock listed?

BBLG stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BONE BIOLOGICS CORP stock?

7 analysts have analysed BBLG and the average price target is 16.83 USD. This implies a price increase of 2251.22% is expected in the next year compared to the current price of 0.7158. Check the BONE BIOLOGICS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BONE BIOLOGICS CORP worth?

BONE BIOLOGICS CORP (BBLG) has a market capitalization of 2.34M USD. This makes BBLG a Nano Cap stock.


How many employees does BONE BIOLOGICS CORP have?

BONE BIOLOGICS CORP (BBLG) currently has 2 employees.


What are the support and resistance levels for BONE BIOLOGICS CORP (BBLG) stock?

BONE BIOLOGICS CORP (BBLG) has a support level at 0.7 and a resistance level at 0.74. Check the full technical report for a detailed analysis of BBLG support and resistance levels.


Should I buy BONE BIOLOGICS CORP (BBLG) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BONE BIOLOGICS CORP (BBLG) stock pay dividends?

BBLG does not pay a dividend.


When does BONE BIOLOGICS CORP (BBLG) report earnings?

BONE BIOLOGICS CORP (BBLG) will report earnings on 2025-05-12, after the market close.


What is the Price/Earnings (PE) ratio of BONE BIOLOGICS CORP (BBLG)?

BONE BIOLOGICS CORP (BBLG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.96).


What is the Short Interest ratio of BONE BIOLOGICS CORP (BBLG) stock?

The outstanding short interest for BONE BIOLOGICS CORP (BBLG) is 6.04% of its float. Check the ownership tab for more information on the BBLG short interest.


BBLG Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BBLG Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BBLG. No worries on liquidiy or solvency for BBLG as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BBLG Financial Highlights

Over the last trailing twelve months BBLG reported a non-GAAP Earnings per Share(EPS) of -4.96. The EPS increased by 92.52% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -189.7%
ROE -210.26%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%75.14%
Sales Q2Q%N/A
EPS 1Y (TTM)92.52%
Revenue 1Y (TTM)N/A

BBLG Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to BBLG. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners2.85%
Ins Owners1.3%
Short Float %6.04%
Short Ratio0.88
Analysts
Analysts82.86
Price Target16.83 (2251.22%)
EPS Next Y59.93%
Revenue Next YearN/A